Ironwood Pharma Beats on All Fronts – Analyst Blog

By | October 18, 2012
0 Comment

Ironwood Pharmaceuticals, Inc.’s ( IRWD ) third-quarter 2012 earnings of 42 cents per share compared favorably with the year-ago loss of 21 cents per share and the Zacks Consensus

View post:
Ironwood Pharma Beats on All Fronts – Analyst Blog

Related posts:

  1. Ironwood Pharma Upped to Strong Buy – Analyst Blog
  2. Valeant Beats on All Fronts – Analyst Blog
  3. AMAG Cuts Loss, Guides Favorably – Analyst Blog
  4. Shire Misses on All Fronts – Analyst Blog